Semaglutide initiation is associated with a lower risk for adult-onset epilepsy or seizures in patients with T2DM, according ...

By Nancy Lapid April 16 (Reuters) - Eli Lilly's GLP-1 drug tirzepatide yields greater weight loss on average than Novo ...

The SURMOUNT-5 trial evaluated the efficacy and safety of tirzepatide compared to semaglutide in adults with obesity or ...

A new study has identified a naturally occurring peptide linked to weight loss. Afraid of taking Ozempic? There’s a way to do ...

More patients on Eli Lilly’s tirzepatide lost over 5% of their lean mass versus those on Novo Nordisk’s semaglutide, ...

Use of certain glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a modestly increased risk for new-onset rheumatoid arthritis (RA), particularly with shorte ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity or ...

CVS Caremark’s preferred-formulary shift from tirzepatide to semaglutide produced a 17-fold jump in tirzepatide switching ...

I first met Jane (not her real name, of course) on a Friday afternoon in our clinic. She was referred for further evaluation of her chest pain, which, in the context of her family history of ...

A large-scale study suggests that GLP-1 drugs could have unexpected mental health benefits, including lower risks of ...

Semaglutide 25 mg tablets were tied to significantly greater mean weight loss vs. orforglipron 36 mg tablets, according to ...

MSN Laboratories launches Semabest, a cost-effective semaglutide generic, enhancing access to diabetes treatment in India.